- Home
- COOK vs CCCC Comparison
COOK vs CCCC Comparison
Compare COOK & CCCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- COOK
- CCCC
- Stock Information
- Founded
- COOK 1985
- CCCC 2015
- Country
- COOK United States
- CCCC United States
- Employees
- COOK N/A
- CCCC N/A
- Industry
- COOK Wholesale Distributors
- CCCC Biotechnology: Pharmaceutical Preparations
- Sector
- COOK Consumer Discretionary
- CCCC Health Care
- Exchange
- COOK Nasdaq
- CCCC Nasdaq
- Market Cap
- COOK 237.8M
- CCCC 244.9M
- IPO Year
- COOK 2021
- CCCC 2020
- Fundamental
- Price
- COOK $1.69
- CCCC $1.52
- Analyst Decision
- COOK Hold
- CCCC Buy
- Analyst Count
- COOK 6
- CCCC 4
- Target Price
- COOK $2.83
- CCCC $12.50
- AVG Volume (30 Days)
- COOK 224.8K
- CCCC 777.7K
- Earning Date
- COOK 05-07-2025
- CCCC 05-07-2025
- Dividend Yield
- COOK N/A
- CCCC N/A
- EPS Growth
- COOK N/A
- CCCC N/A
- EPS
- COOK N/A
- CCCC N/A
- Revenue
- COOK $604,072,000.00
- CCCC $35,584,000.00
- Revenue This Year
- COOK $2.02
- CCCC N/A
- Revenue Next Year
- COOK $5.30
- CCCC $36.32
- P/E Ratio
- COOK N/A
- CCCC N/A
- Revenue Growth
- COOK N/A
- CCCC 71.44
- 52 Week Low
- COOK $1.61
- CCCC $1.39
- 52 Week High
- COOK $3.97
- CCCC $8.08
- Technical
- Relative Strength Index (RSI)
- COOK 30.47
- CCCC 25.37
- Support Level
- COOK $1.61
- CCCC $1.79
- Resistance Level
- COOK $1.89
- CCCC $2.28
- Average True Range (ATR)
- COOK 0.10
- CCCC 0.15
- MACD
- COOK 0.01
- CCCC -0.02
- Stochastic Oscillator
- COOK 28.57
- CCCC 14.61
About COOK Traeger Inc.
Traeger Inc designs, sources, sells, and supports wood pellet fueled barbeque grills sold to retailers, distributors, and direct to consumers. It produces and sells the pellets used to fire the grills and also sells Traeger-branded rubs, spices, and sauces, as well as grilling accessories including covers, barbeque tools, trays, liners, and merchandise. The company's geographical segments include North America and the Rest of the world, of which majority of revenue is from North America.
About CCCC C4 Therapeutics Inc.
C4 Therapeutics Inc is a biopharmaceutical company advancing targeted protein degradation science to develop a new generation of small-molecular medicines to transform how the disease is treated. Its TORPEDO platform enables the discovery of a new class of targeted investigational small-molecule medicines called protein degraders.